Related Experiment Videos
Epilepsy in neurofibromatosis 1
Rossella Vivarelli1, Salvatore Grosso, Fulvia Calabrese
1Department of Pediatrics, University of Siena, Siena, Italy.
Journal of Child Neurology
|June 26, 2003
Summary
Neurofibromatosis 1 (NF1) patients have a higher risk of epilepsy, often linked to brain tumors or malformations. Seizures can be the first sign of these conditions in NF1.
Area of Science:
- Neurology
- Genetics
- Oncology
Background:
- Neurofibromatosis 1 (NF1) is a common genetic disorder affecting the nervous system.
- Neurologic issues in NF1 include tumors, cognitive deficits, and seizures.
- Previous studies report epilepsy prevalence in NF1 ranging from 3.8% to 6%.
Observation:
- This study analyzed 198 patients with NF1 to determine epilepsy prevalence, type, and causes.
- Epilepsy was identified in 14 patients (7%), with partial seizures in 85% and generalized in 15%.
- Brain lesions, including tumors and cortical malformations, were the cause of epilepsy in 64% of cases.
Findings:
- Epilepsy in NF1 is frequently associated with intracranial masses and cytoarchitectural abnormalities.
- Seizures can be the initial symptom of a brain tumor or cortical malformation in NF1 patients.
- Rapid seizure control was achieved in 57% of patients, while 29% had drug-resistant epilepsy.
Implications:
- Patients with NF1 have an elevated risk of epilepsy due to associated brain abnormalities.
- Early diagnosis and management of epilepsy are crucial in NF1.
- Neuroimaging, particularly MRI, is vital for evaluating seizures in NF1, especially when cognitive impairment is present.